Who are MBM 5 Large Intestine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Arnicare Leg Cramps, Cimicifuga racemosa.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/senna-cassia.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

MBM 5 Large Intestine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MBM 5 Large Intestine (SENNA+CASSIA) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Copper-containing Intrauterine Device [EPC]. Area: Metabolic.

marketed Copper-containing Intrauterine Device [EPC] Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

MBM 5 Large Intestine (SENNA+CASSIA) — The Wellness Center.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Approval / PDUFA
MBM 5 Large Intestine TARGET	SENNA+CASSIA	The Wellness Center	marketed	Copper-containing Intrauterine Device [EPC]
Arnicare Leg Cramps	COPPER	Sebela Womens Hlth	marketed	Copper-containing Intrauterine Device [EPC]	2026-01-01
Cimicifuga racemosa	Cimicifuga racemosa	Irmandade da Santa Casa de Misericordia de Sao Paulo	marketed	Copper-containing Intrauterine Device [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2032-08-14 — Arnicare Leg Cramps · 10188546 · Formulation · US
2032-08-14 — Arnicare Leg Cramps · 10159596 · Formulation · US
2032-08-14 — Arnicare Leg Cramps · 9427351 · Formulation · US
2032-08-14 — Arnicare Leg Cramps · 11850181 · Formulation · US
2033-04-09 — Arnicare Leg Cramps · 9089418 · Formulation · US
2033-10-18 — Arnicare Leg Cramps · 12138199 · Formulation · US
2034-02-24 — Arnicare Leg Cramps · 9610191 · Method of Use · US
2034-02-24 — Arnicare Leg Cramps · 10398588 · Formulation · US
2034-03-22 — Arnicare Leg Cramps · 10022264 · Formulation · US
2034-04-28 — Arnicare Leg Cramps · 9265652 · Method of Use · US
2034-06-13 — Arnicare Leg Cramps · 10166141 · Formulation · US
2034-08-16 — Arnicare Leg Cramps · 11207209 · Formulation · US
2037-01-23 — Arnicare Leg Cramps · 10918516 · Formulation · US

Sponsor landscape (Copper-containing Intrauterine Device [EPC] class)

Irmandade da Santa Casa de Misericordia de Sao Paulo · 1 drug in this class
Sebela Womens Hlth · 1 drug in this class
The Wellness Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MBM 5 Large Intestine — Competitive Intelligence Brief. https://druglandscape.com/ci/senna-cassia. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing